Chagee gains after Jefferies says the market is overly bearish on the brand recovery (CHA:NASDAQ)

Chagee (CHA) reported Q2 2026 earnings with net revenues of RMB 3,414.6 million, up 2.5% YoY. Company-owned teahouse revenue surged 222.2% YoY, while total GMV fell 3.3% sequentially. Overseas GMV grew 114.3% YoY. GAAP operating income increased 387.6% due to cost management. Management highlighted economic headwinds and competition in Greater China but emphasized high-quality growth and overseas expansion.

Chagee Holdings Ltd. (CHA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Chagee Announces Second Quarter 2026 Unaudited Financial Results SHANGHAI, August 28, 2026 (GLOBE NEWSWIRE) -- Chagee Holdings Limited (NASDAQ: CHA) (“Chagee” or the “Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks,

Chagee Holdings (NASDAQ: CHA) reported first-quarter 2026 unaudited results for the period ended March 31, 2026. Net revenues rose to RMB3,546.0 million (US$514.1 million) from RMB3,392.7 million a year earlier, but operating income fell to RMB547.2 million and GAAP net income to RMB447.7 million. Total GMV was RMB7,917.8 million; teahouses increased 12.7% to 7,531. The company also authorized a US$150 million share repurchase program.

The article previews a short U.S. and Canada market week after Memorial Day, highlighting housing, confidence, jobs, and earnings. It lists U.S. EPS results for PDD, AutoZone, Elbit, Salesforce, Synopsys, Marvell, Costco, Dell, and Autodesk, plus Canada banks’ and other firms’ EPS. Key data include S&P Case-Shiller (March), jobless claims and durable goods (May 23/April), and Canada payroll employment and GDP.

Helus Pharma (HELP) announced updates on its mental health drug programs. HLP003 Phase 3 data readout is on track for Q4 2026, with FDA Breakthrough Therapy Designation. HLP004 Phase 2 monotherapy study for GAD is expected to start in Q1 2027, enrolling 144 adults. The company aims for FDA filing in 2028.

United States Antimony (UAMY) is expanding capacity due to defense contracts, including a $245M DLA contract for antimony metal ingots. The company also secured a $106M contract for flame-retardant materials. A joint venture with Americas Gold and Silver aims to build a hydrometallurgical facility, increasing total capacity to 1,500 tons/month. Revenue grew from $8M in 2023 to $39M in 2024, but guidance was reduced to $60M-$75M due to price declines.